Kimberly L. Jordan

Array ( [id] => 1560098 [patent_doc_number] => 06436898 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Compounds for treatment of infectious and immune system disorders and methods for their use' [patent_app_type] => B1 [patent_app_number] => 09/351348 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16322 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436898.pdf [firstpage_image] =>[orig_patent_app_number] => 09351348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1598755 [patent_doc_number] => 06475480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Use of adenoviral E4 reading frames to improve expression of a gene of interest' [patent_app_type] => B1 [patent_app_number] => 09/348049 [patent_app_country] => US [patent_app_date] => 1999-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11856 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475480.pdf [firstpage_image] =>[orig_patent_app_number] => 09348049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473126 [patent_doc_number] => 06387367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Human mesenchymal stem cells' [patent_app_type] => B1 [patent_app_number] => 09/321924 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10365 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387367.pdf [firstpage_image] =>[orig_patent_app_number] => 09321924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579361 [patent_doc_number] => 06448390 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Stable envelope proteins for retroviral, viral and liposome vectors and use in gene drug therapy' [patent_app_type] => B1 [patent_app_number] => 09/315127 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 45 [patent_no_of_words] => 42787 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448390.pdf [firstpage_image] =>[orig_patent_app_number] => 09315127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516273 [patent_doc_number] => 06500421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'In vivo selection of primitive hematopoietic cells' [patent_app_type] => B1 [patent_app_number] => 09/297749 [patent_app_country] => US [patent_app_date] => 1999-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 13720 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500421.pdf [firstpage_image] =>[orig_patent_app_number] => 09297749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327477 [patent_doc_number] => 06312898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Diagnosis of a person\'s risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene' [patent_app_type] => 1 [patent_app_number] => 9/291994 [patent_app_country] => US [patent_app_date] => 1999-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6211 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312898.pdf [firstpage_image] =>[orig_patent_app_number] => 291994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288716 [patent_doc_number] => 06235522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Lentiviral vectors' [patent_app_type] => 1 [patent_app_number] => 9/284011 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5214 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235522.pdf [firstpage_image] =>[orig_patent_app_number] => 284011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367787 [patent_doc_number] => 06287856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Vaccines against circovirus infections' [patent_app_type] => 1 [patent_app_number] => 9/267177 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17901 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287856.pdf [firstpage_image] =>[orig_patent_app_number] => 267177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306869 [patent_doc_number] => 06252057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Protein targeting to glycogen' [patent_app_type] => 1 [patent_app_number] => 9/242948 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 12449 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252057.pdf [firstpage_image] =>[orig_patent_app_number] => 242948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284863 [patent_doc_number] => 06210946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Modified adenovirus containing a fiber replacement protein' [patent_app_type] => 1 [patent_app_number] => 9/250580 [patent_app_country] => US [patent_app_date] => 1999-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6013 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210946.pdf [firstpage_image] =>[orig_patent_app_number] => 250580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1502324 [patent_doc_number] => 06464973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Universal GM-CSF expressing bystander human K562 cell line' [patent_app_type] => B1 [patent_app_number] => 09/241939 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6961 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/464/06464973.pdf [firstpage_image] =>[orig_patent_app_number] => 09241939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419182 [patent_doc_number] => 06521814 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Use of ligands for treatment of diseases responsive to retinoids' [patent_app_type] => B1 [patent_app_number] => 09/218446 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 124 [patent_no_of_words] => 45514 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521814.pdf [firstpage_image] =>[orig_patent_app_number] => 09218446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433301 [patent_doc_number] => 06340591 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Integrative protein-DNA cochleate formulations and methods for transforming cells' [patent_app_type] => B1 [patent_app_number] => 09/210578 [patent_app_country] => US [patent_app_date] => 1998-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7066 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340591.pdf [firstpage_image] =>[orig_patent_app_number] => 09210578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514254 [patent_doc_number] => 06420120 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Use of a polypeptide as cell receptor for adenoviruses' [patent_app_type] => B1 [patent_app_number] => 09/155613 [patent_app_country] => US [patent_app_date] => 1998-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 12373 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420120.pdf [firstpage_image] =>[orig_patent_app_number] => 09155613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314863 [patent_doc_number] => 06316609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Nucleotide sequence of Escherichia coli pathogenicity islands' [patent_app_type] => 1 [patent_app_number] => 8/976259 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 62369 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316609.pdf [firstpage_image] =>[orig_patent_app_number] => 976259 [rel_patent_id] =>[rel_patent_doc_number] =>)